Compound name
ABBV-744
Protein family
Bromodomain
Target name
BRD2@BD2
Affinity biochemical (nM)
4.6
CG-Set
Epigenetic set
Recommended Concentration
1 µM
Compound EUbOPEN ID
EUB0000246b
SMILES
CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1
InChIKey
OEDSFMUSNZDJFD-UHFFFAOYSA-N
NCBI gene ID
6046
UniProt ID
P25440
Synonyms
KIAA9001, RING3, D6S113E, NAT, FSRG1
Mode of action
Inhibitor
Affinity biochemical definition
Ki
Affinity biochemical assay type
TR-FRET binding assay (BD2)
Affinity Biochemical Source Knowledge
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00628
Affinity biochemical relation
0
Selectivity platform
BROMOScan (Discoverx)
Selectivity platform number of targets
22
Selectivity remarks
290-fold selectivity relative to the BD1 domains of BRD2, BRD3 and BRD4; Clean in screen against 75 kinases
Selectivity Source Knowledge
https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00628
Selectivity Number of Off-targets
0